Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke with and without metabolic syndrome

Table 5 Correlations of AIx with clinical variables and cardiovascular risk factors in relation to TOAST stroke subtype

	Lacunar			LAAS			CEI
Variable	Augmentation Index (AIx)		P	Augmentation Index (AIx)		P	Augmentation Index (AIx)		P
Variable	With metabolic syndrome (n: 45)	Without metabolic syndrome (n: 37)	0	With metabolic syndrome (n: 45)	Without metabolic syndrome (n: 37)		With metabolic syndrome (n:32)	Without metabolic syndrome (n:35)
CRP	0.24	0.26	0.73	0.27	0.26	0.81	0.20	0.21	0.73
IL-1-β	0.21	0.22	0.60	0.24	0.25	0.66	0.20	0.22	0.56
IL-6	0.31	0.25	0.026	0.34	0.226	0.011	0.33	0.23	0.022
TNF-α	0.33	0.27	0.022	0.32	0.26	0.033	0.32	0.26	0.033
E-selectin	0.20	0.27	0.56	0.19	0.21	0.56	0.19	0.21	0.56
P-selectin	0.19	0.15	0.33	0.18	0.16	0.44	0.18	0.16	0.44
VICAM-1	0.21	0.22	0.66	0.22	0.21	0.66	0.20	0.22	0.66
ICAM-1	0.22	0.24	0.63	0.20	0.24	0.63	0.22	0.24	0.63
IL-10	0.22	0. 23	0.56	0.22	0. 23	0.56	0.22	0. 23	0.56
vWF	0.36	0.30	0.020	0.33	0.27	0.029	0.36	0.32	0.018
PAI-1	0.19	0.14	0.64	0.16	0.14	0.77	0.18	0.15	0.77
TPA	0.22	0.25	0.77	0.20	0.21	0.69	0.20	0.21	0.69
									<0.05
									0.033

Coefficients (r) and p-values are calculated by the Pearson correlation mode.
SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial pressure; AIx: augmentation index; PWV: pulse wave velocity; SSS: Scandinavian Stroke Scale score; NIHSS: National Institutes of Health Stroke Scale ; Angiotensin II receptor blockers (ARBs); CAD: coronary artery disease; CHF: congestive heart failure; LVH: left ventricular hypertrophy; WMHLS: white matter hypertension lesions. Demographic and history data are expressed as n° (percentage). Significant R and p are in bold.

ISSN: 1758-5996